Studies have demonstrated that the TGFβ1-Smad signalling pathway is involved in the progression and prognosis of several types of carcinomas, including oesophageal (9), colorectal (10) and gastric (11) carcinoma. This evidence concerns the gene TGFB1 and carcinoma.